Synthesis and phosphodiesterase 5 inhibitory activity of new 5-phenyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one derivatives containing an N-acylamido group on a phenyl ring
- 1 July 2001
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 9 (7) , 1895-1899
- https://doi.org/10.1016/s0968-0896(01)00095-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor:: Research and Clinical Implications in Erectile DysfunctionTrends in Endocrinology & Metabolism, 1999
- Phosphodiesterase inhibitors in the treatment of erectile dysfunctionDrugs of Today, 1998
- The role of phosphodiesterase inhibitors in impotenceExpert Opinion on Investigational Drugs, 1997
- Drugs for the Treatment of ImpotenceDrugs & Aging, 1997
- SildenafilDrugs of the Future, 1997
- Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunctionBioorganic & Medicinal Chemistry Letters, 1996
- Synthesis and Cyclic GMP Phosphodiesterase Inhibitory Activity of a Series of 6-Phenylpyrazolo[3,4-d]pyrimidonesJournal of Medicinal Chemistry, 1996
- Cyclic nucleotide phosphodiesterases: functional implications of multiple isoformsPhysiological Reviews, 1995
- Physiology of penile erectionPhysiological Reviews, 1995
- Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging StudyJournal of Urology, 1994